Factor X deficiency

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 4, 2009, Pages 407-415

  Menegatti, Marzia ^a   Peyvandi, Flora ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bleeding disorders; Factor X; Factor X deficiency; Gene mutations; Replacement therapy

Indexed keywords

BEBULIN VH; BERIPLEX; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 9 COMPLEX; COFACT; FACTOR X P; FANCNYNE; FRESH FROZEN PLASMA; HAEMOSOLVEX; HT DEFIX; HUMAN COMPLEX D I; KASKADILL; OCTAPLEX; PPSB HUMAN SD; PROPHILNINE SD; PROTHROMBIN COMPLEX; PROTHROMBINEX VF; PROTHROMPLEX T; PROTHRORAAS; TRANEXAMIC ACID; UNCLASSIFIED DRUG; VITAMIN K GROUP;

BLOOD CLOTTING FACTOR 10 DEFICIENCY; CHROMOSOME 13; CLINICAL FEATURE; DISEASE ASSOCIATION; DNA EXTRACTION; EXON; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HEMARTHROSIS; HUMAN; IN VITRO STUDY; MENORRHAGIA; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTHROMBIN TIME; REVIEW; SUBSTITUTION THERAPY; THROMBOEMBOLISM;

ANTIGENS; BLOOD COAGULATION FACTORS; FACTOR X; FACTOR X DEFICIENCY; FEMALE; GENOTYPE; HEMORRHAGE; HUMANS; MENORRHAGIA; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; PREGNANCY; PRENATAL DIAGNOSIS; PROTHROMBIN TIME;

EID: 67749099616     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1225763     Document Type: Review

References (67)

1. Telfer TP, Denson KW, Wright DR. A new coagulation defect. Br J Haematol 1956;2:308-316
2. Hougie C, Barrow EM, Graham JB. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. J Clin Invest 1957;36: 485-496
3. Wright IS. The nomenclature of blood clotting factors. Thromb Diath Haemorrh 1962;7:381-388
4. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243-1252
5. Bajaj SP, Mann KG. Simultaneous purification of bovine prothrombin and factor X. Activation of prothrombin by trypsin-activated factor X. J Biol Chem 1973;248:7729-7741
6. Ichinose A, Takeya H, Espling E, Iwanaga S, Kisiel W, Davie EW. Amino acid sequence of human protein Z, a vitamin K-dependent plasma glycoprotein. Biochem Biophys Res Commun 1990;172:1139-1144
7. Leytus SP, Foster DC, Kurachi K, Davie EW. Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry 1986;25:5098-5102 (Pubitemid 17016521)
8. Suttie JW. Vitamin K-dependent carboxylase. Annu Rev Biochem 1985;54:459-477
9. McMullen BA, Fujikawa K, Kisiel W, et al. Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identification of residue 63 as beta-hydroxyaspartic acid. Biochemistry 1983;22:2875-2884
10. Fujikawa K, Coan MH, Legaz ME, Davie EW. The mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways. Biochemistry 1974;13: 5290-5299
11. Kisiel W, Hermodson MA, Davie EW. Factor X activating enzyme from Russell's viper venom: isolation and characterization. Biochemistry 1976;15:4901-4906
12. Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988;53:505-518
13. Peyvandi F, Mannucci PM, Lak M, et al. Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients. Br J Haematol 1998;102:626-628 (Pubitemid 28346611)
14. Herrmann FH, Auerswald G, Ruiz-Saez A, et al; The Greifswald Factor X Deficiency Study Group. Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene. Haemophilia 2006;12:479-489
15. Karimi M, Menegatti M, Afrasiabi A, Sarikhani S, Peyvandi F. Phenotype and genotype report on homozygous and heterozygous patients with congenital factor X deficiency. Haematologica 2008;93:934-938 (Pubitemid 351821734)
16. Peyvandi F, Menegatti M, Santagostino E, et al. Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency. Br J Haematol 2002;117:685-692 (Pubitemid 34539247)
17. Mulhare PE, Tracy PB, Golden EA, Branda RF, Bovill EG. A case of acquired factor X deficiency with in vivo and in vitro evidence of inhibitor activity directed against factor X. Am J Clin Pathol 1991;96:196-200
18. Matsunaga AT, Shafer FE. An acquired inhibitor to factor X in a pediatric patient with extensive burns. J Pediatr Hematol Oncol 1996;18:223-226 (Pubitemid 26163487)
19. Gallais V, Bredoux H, le Roux G, Laroche L. Acquired and transient factor X deficiency associated with sodium valproate treatment. Eur J Haematol 1996;57:330 (Pubitemid 26413129)
20. Lankiewicz MW, Bell WR. A unique circulating inhibitor with specificity for coagulation factor X. Am J Med 1992; 93:343-346
21. Fair DS, Edgington TS. Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analyses. Br J Haematol 1985;59:235-248 (Pubitemid 15151596)
22. Girolami A, Scarparo P, Scandellari R, Allemand E. Congenital factor X deficiencies with a defect only or predominantly in the extrinsic or in the intrinsic system: a critical evaluation. Am J Hematol 2008;83:668-671
23. Pfeiffer RA, Ott R, Gilgenkrantz S, Alexandre P. Deficiency of coagulation factors VII and X associated with deletion of a chromosome 13 (q34). Evidence from two cases with 46,XY,t(13;Y)(q11;q34). Hum Genet 1982;62:358-360
24. Krawczak M, Wacey A, Cooper DN. Molecular reconstruction and homology modelling of the catalytic domain of the common ancestor of the haemostatic vitamin-K-dependent serine proteinases. Hum Genet 1996;98:351-370 (Pubitemid 26258389)
25. Fung MR, Hay CW, MacGillivray RT. Characterization of an almost full-length cDNA coding for human blood coagulation factor X. Proc Natl Acad Sci U S A 1985;82:3591-3595 (Pubitemid 15243890)
26. Leytus SP, Chung DW, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor X. Proc Natl Acad Sci U S A 1984;81:3699-3702 (Pubitemid 14087791)
27. Hung HL, High KA. Liver-enriched transcription factor HNF-4 and ubiquitous factor NF-Y are critical for expression of blood coagulation factor X. J Biol Chem 1996;271:2323-2331
28. Hung HL, Pollak ES, Kudaravalli RD, Arruda V, Chu K, High KA. Regulation of human coagulation factor X gene expression by GATA-4 and the Sp family of transcription factors. Blood 2001;97:946-951 (Pubitemid 32154278)
29. Zivelin A, Seligsohn U. Mutations causing rare bleeding disorders. 2007. Available at: http://www.org/publication/registriesdatabases/ mutationsrarebleedingdisorders/factorX. aspx. Accessed June 18, 2009
30. Camire RM, Murphy SL, Day GAIII, High KA. Identi- fication and characterization of mutations leading to factor X deficiency. Thromb Haemost 2001;(Suppl):OC1030
31. Akhavan S, Chafa O, Nsoure Obame F, et al. Factor X gene mutations affecting the Gla domain of the protein. Thromb Haemost 2005;3(Suppl 1):1446
32. Ingerslev J, Herlin T, Sørensen B, Clausen N, Chu KC, High KA. Severe factor X deficiency in a pair of siblings: clinical presentation, phenotypic and genotypic features, prenatal diagnosis and treatment. Haemophilia 2007;13: 334-336 (Pubitemid 46746060)
33. Al-Hilali A, Wulff K, Abdel-Razeq H, Saud KA, Al-Gaili F, Herrmann FH. Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly. Thromb Haemost 2007;97:542-545 (Pubitemid 46592930)
34. Zivelin A, Salomon O, Kenet G, et al. Cys61stop is the first identified nonsense mutation in the factor X gene causing severe factor X deficiency in 3 unrelated homozygotes of Arab origin. J Thromb Haemost 2003;1(Suppl 1):1211
35. Shinohara K, Adachi M, Matsui K, Matsuda K, Nagaya S, Morishita E. A case of factor X (FX) deficiency due to novel mutation V196M, FX Hofu. Int J Hematol 2008;87:256-259
36. Morishita E, Ueda A, Asakura H, et al. Molecular genetic analysis of factor X deficiency (factor X Ohmura): identification of a novel gene alteration in Japanese family. Thromb Haemost 2001;(Suppl):CD3372
37. Bereczky Z, Kiss C, Szaboò T, et al. Three novel missense mutations and their functional consequences in two severe inherited factor X deficiencies. J Thromb Haemost 2005; 3(Suppl 1):OR123
38. Ameri A, Machiah DK, Tran TT, et al. A nonstop mutation in the factor (F)X gene of a severely haemorrhagic patient with complete absence of coagulation FX. Thromb Haemost 2007;98:1165-1169 (Pubitemid 350239086)
39. Miao CH, Leytus SP, Chung DW, Davie EW. Liver-specific expression of the gene coding for human factor X, a blood coagulation factor. J Biol Chem 1992;267:7395-7401
40. Huang MN, Hung HL, Stanfield-Oakley SA, High KA. Characterization of the human blood coagulation factor X promoter. J Biol Chem 1992;267:15440-15446
41. Wang WB, Fu QH, Yin J, et al. Factor X Shanghai and disruption of translocation to the endoplasmic reticulum. Haematologica 2005;90:1659-1664 (Pubitemid 41814991)
42. Racchi M, Watzke HH, High KA, Lively MO. Human coagulation factor X deficiency caused by a mutant signal peptide that blocks cleavage by signal peptidase but not targeting and translocation to the endoplasmic reticulum. J Biol Chem 1993;268:5735-5740 (Pubitemid 23090900)
43. Rudolph AE, Mullane MP, Porche-Sorbet R, Tsuda S, Miletich JP. Factor X St. Louis II Identification of a glycine substitution at residue 7 and characterization of the recombinant protein. J Biol Chem 1996;271:28601-28606 (Pubitemid 26374684)
44. Pinotti M, Marchetti G, Baroni M, Cinotti F, Morfini M, Bernardi F. Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency. Thromb Haemost 2002;88:236-241 (Pubitemid 34873704)
45. Nöbauer-Huhmann IM, Höller W, Krinninger B, et al. Factor X Frankfurt I: molecular and functional characterization of a hereditary factor X deficiency (Gla+25 to Lys). Blood Coagul Fibrinolysis 1998;9:143-152 (Pubitemid 28216259)
46. Bereczky Z, Bárdos H, Komáromi I, et al. Factor XDebrecen: Gly204Arg mutation in factor X causes the synthesis of a non-secretable protein and severe factor X deficiency. Haematologica 2008;93:299-302
47. Pinotti M, Monti M, Baroni M, Marchetti G, Bernardi F. Molecular characterization of factor X deficiency associated with borderline plasma factor X level. Haematologica 2004; 89:501-502 (Pubitemid 38798560)
48. Wang WB, Fu QH, Zhou RF, et al. Molecular characterization of two novel mutations causing factor X deficiency in a Chinese pedigree. Haemophilia 2005;11:31-37
49. Isshiki I, Favier R, Moriki T, et al. Genetic analysis of hereditary factor X deficiency in a French patient of Sri Lankan ancestry: in vitro expression study identified Gly366Ser substitution as the molecular basis of the dysfunctional factor X. Blood Coagul Fibrinolysis 2005;16:9-16
50. Pinotti M, Camire RM, Baroni M, Rajab A, Marchetti G, Bernardi F. Impaired prothrombinase activity of factor X Gly381Asp results in severe familial CRM+FX deficiency. Thromb Haemost 2003;89:243-248 (Pubitemid 36227274)
51. Girolami A, Randi ML, Tezza F, Molaro G, Girolami B. Unusual longevity in a patient with factor X Friuli coagulation disorder. Thromb Haemost 2005;93:385-387 (Pubitemid 40253750)
52. Dewerchin M, Liang Z, Moons L, et al. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost 2000;83: 185-190 (Pubitemid 30093216)
53. Ingerslev J, Sørensen B, Castaman G, Lloyd JV, Varon JD, Savion N. New approaches in the measurement of coagulation. Haemophilia 2008;14(Suppl 3):104-112
54. Bernardi F, Marchetti G, Patracchini P, et al. Partial gene deletion in a family with factor X deficiency. Blood 1989;73: 2123-2127 (Pubitemid 19179543)
55. Wieland K, Millar DS, Grundy CB, Mibashan RS, Kakkar VV, Cooper DN. Molecular genetic analysis of factor X deficiency: gene deletion and germline mosaicism. Hum Genet 1991;86:273-278
56. Millar DS, Elliston L, Deex P, et al. Molecular analysis of the genotype-phenotype relationship in factor X deficiency. Hum Genet 2000;106:249-257 (Pubitemid 30156431)
57. Bolton-maggs PH, Perry DJ, Chalmers EA, et al. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004;10:593-628
58. Al Dieri R, Peyvandi F, Santagostino E, et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002;88:576-582 (Pubitemid 35173997)
59. Auerswald G. Prophylaxis in rare coagulation disorders - factor X deficiency. Thromb Res 2006;118(Suppl 1):S29-S31
60. McMahon C, Smith J, Goonan C, Byrne M, Smith OP. The role of primary prophylactic factor replacement therapy in children with severe factor X deficiency. Br J Haematol 2002;119:789-791 (Pubitemid 35366225)
61. Kouides PA, Kulzer L. Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate. Haemophilia 2001;7:220-223 (Pubitemid 32243806)
62. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999;107:204-206 (Pubitemid 29500827)
63. Lak M, Peyvandi F, Ali Sharifian A, Karimi K, Mannucci PM. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 2003;1:1852-1853
64. Gupta N, Dadhwal V, Deka D, Jain SK, Mittal S. Corpus luteum hemorrhage: rare complication of congenital and acquired coagulation abnormalities. J Obstet Gynaecol Res 2007;33:376-380 (Pubitemid 46934562)
65. Payne JH, Maclean RM, Hampton KK, Baxter AJ, Makris M. Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill. Haemophilia 2007;13:93-97 (Pubitemid 46002352)
66. Condie RG. A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia. Br J Obstet Gynaecol 1976; 83:636-639
67. Kumar M, Mehta P. Congenital coagulopathies and pregnancy: report of four pregnancies in a factor X-deficient woman. Am J Hematol 1994;46:241-244 (Pubitemid 24206752)